Lexaria Bioscience Corp. — Director's Dealing 2024

Aug 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2024-08-12

Reporting Person: TURKEL CATHERINE C. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-12	common shares	P	1600	$3.13	Acquired	3100	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	1500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3.04	2027-09-02	Common Shares (3400)	3400	Direct
Stock Options	$1.96	2027-10-12	Common Shares (1600)	5000	Direct
Stock Options	$0.87	2028-07-25	Common Shares (5000)	10000	Direct
Stock Options	$2.36	2029-04-26	Common Shares (5000)	15000	Direct
Stock Options	$3.39	2029-07-26	Common Shares (12000)	27000	Direct